PMLuiz

[PMLuiz @PMLuiz1]

Great presentation from @jrzalcberg on the access to #biomarker testing in #Asia. It is important to increase access to testing which can positively impact patients outcomes.
#bettertesting #ESMOAsia23

[PMLuiz @PMLuiz1]

2,5 days of very interesting discussions on the use and future direction of #liquidbiopsy @isliquidbiopsy
@UmbertoMalapel1
@drgandara @MJOSESERRANO19 @ChristianRolfo @ElJanLe @MCristofanill

[PMLuiz @PMLuiz1]

@drgandara on the views of @ISLB
#educate #facilitate #innovate #affiliate #deliberate #adjudicate

[Yüksel Ürün @DrYukselUrun]

Dr. Masahiro Tsuboi 🇯🇵 has highlighted the future of early lung cancer detection with a focus on a miRNA biomarker panel, this approach may revolutionize early detection, showcasing potential beyond current imaging techniques.

@isliquidbiopsy @ChristianRolfo @drgandara @UmbertoMalapel1 @MCristofanill @pashtoonkasi @OncoAlert #ISLB23

[Yüksel Ürün @DrYukselUrun]

The EMPower-Lung 1 Study design presents a novel approach to NSCLC treatment
🧬🧬early ctDNA changes at 3 weeks correlate highly with survival rates, presenting a pivotal marker for both Cemiplimab and chemotherapy efficacy.

@isliquidbiopsy @ChristianRolfo @drgandara @UmbertoMalapel1 @MCristofanill @pashtoonkasi @OncoAlert

[Pashtoon Kasi MD, MS @pashtoonkasi]

🩸#ISLB23 So glad to be present at the kickoff of @isliquidbiopsy 2023, Madrid, Spain.🇪🇸

Nothing better than focusing on Young Committee Career Session - on the future of #LiquidBiopsies.🧬

Love being a part of this.

Become a member:
➡️https://t.co/BRJGgpZ5fn

@OncoAlert

[PMLuiz @PMLuiz1]

In order to correct identify patients we need more testing!
All room in agreement with @ChristianRolfo.
#bettertesting #ESMO2023

[PMLuiz @PMLuiz1]

Breathtaking presentation of @dplanchard on the future of #ADC treatment in #lung cancer. Looking forward to the future with personalised ADC

[PMLuiz @PMLuiz1]

#TKI and #chemotherapy are not for all #NSCLC patients. More time should be spent on the #NGS and #biomarker results to better decide the treatment decisions. Great insight from @JulienMazieres
#bettertesting

[PMLuiz @PMLuiz1]

Overview of resistance pathways for TKI treatments in lung cancer by @JulienMazieres during the 4th joint meeting Lung Cancer in Nice.
#bettertesting

[PMLuiz @PMLuiz1]

Federico Rojo on the importance of the pre-analytical phase for the outcome of #NGS and the impact on correctly identifying #cancer #patients
#bettertesting

[PMLuiz @PMLuiz1]

Great insight and positioning from Roberto Salgado. We as a collective should change how we face #CDx and work on developing assays that address a biological question and not only to be validated by a trial.
#ESPCongress 2023

[PMLuiz @PMLuiz1]

@ChristianRolfo @IASLC @UmbertoMalapel1 @dplanchard I am sure it was an outstanding session. Looking forward to seeing you at #ECP2023 on Monday!

[PMLuiz @PMLuiz1]

@MamMa_mimumemo Good luck in the new start!

[PMLuiz @PMLuiz1]

@MamMa_mimumemo So nice to see your booth at JBCS

[PMLuiz @PMLuiz1]

@ChristianRolfo @MariantoniaNac1 @UmbertoMalapel1 @isliquidbiopsy @UninaIT @FlyingBrussels Nobody can compete with it @ChristianRolfo
The only thing I can do is keep trying

[PMLuiz @PMLuiz1]

@ChristianRolfo @DrRoyHerbstYale Testing testing testing

[PMLuiz @PMLuiz1]

@PenaultLlorca It might take some time in the queue

[PMLuiz @PMLuiz1]

Good morning Chicago. It is great to be back and already warming up for #ASCO23 looking forward to meeting old and new friends and contributing toward improving biomarker testing.
#bettertesting #biomarker #oncology

[PMLuiz @PMLuiz1]

@MamMa_mimumemo @kazuki_nozawa Congratulations